During the last session, NKGen Biotech Inc (NASDAQ:NKGN)’s traded shares were 0.52 million, with the beta value of the company hitting 0.57. At the end of the trading day, the stock’s price was $0.36, reflecting an intraday gain of 15.61% or $0.05. The 52-week high for the NKGN share is $4.06, that puts it down -1027.78 from that peak though still a striking 44.44% gain since the share price plummeted to a 52-week low of $0.20. The company’s market capitalization is $12.86M, and the average intraday trading volume over the past 10 days was 0.93 million shares, and the average trade volume was 1.21 million shares over the past three months.
NKGen Biotech Inc (NASDAQ:NKGN) trade information
NKGen Biotech Inc (NKGN) registered a 15.61% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 15.61% in intraday trading to $0.36, hitting a weekly high. The stock’s 5-day price performance is 30.59%, and it has moved by -5.96% in 30 days. Based on these gigs, the overall price performance for the year is -86.96%. The short interest in NKGen Biotech Inc (NASDAQ:NKGN) is 0.71 million shares and it means that shorts have 0.29 day(s) to cover.
NKGN Dividends
NKGen Biotech Inc is due to release its next quarterly earnings in December. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
NKGen Biotech Inc (NASDAQ:NKGN)’s Major holders
NKGen Biotech Inc insiders own 42.32% of total outstanding shares while institutional holders control 12.20%, with the float percentage being 21.15%.
Also, the Mutual Funds coming in first place with the largest holdings of NKGen Biotech Inc (NKGN) shares are Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund. Data provided on Sep 30, 2024 indicates that Fidelity Extended Market Index Fund owns about 68.97 shares. This amounts to just over 0.20 percent of the company’s overall shares, with a $26821.0 market value. The same data shows that the other fund manager holds slightly less at 53.8, or about 0.15% of the stock, which is worth about $20924.0.
